페트리 접시 시장 규모, 점유율, 성장 및 세계의 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of petri dishes Market

The global petri dishes market was valued at USD 429.5 million in 2025 and is projected to grow from USD 446.8 million in 2026 to USD 646.1 million by 2034, exhibiting a CAGR of 4.70% during the forecast period (2026-2034). In 2025, North America dominated the market with a 40.20% share, supported by strong pharmaceutical R&D investments and expanding healthcare infrastructure.

Petri dishes are shallow, lidded plates made of glass or plastic, widely used for culturing microorganisms, testing antibiotic efficacy, and conducting microbiological research. Growing prevalence of chronic and infectious diseases is increasing the demand for drugs, vaccines, and therapies, thereby fueling research activities and boosting demand for labware products such as petri dishes.

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the global market. Increased research activities related to vaccine development, treatment discovery, and chronic disease studies led to a surge in labware demand.

According to the National Center for Science and Engineering Statistics, U.S. R&D investment increased by 16.2% to USD 716.95 billion in 2020, compared to USD 666.15 billion in 2019. Thermo Fisher Scientific reported a 77.5% growth in its life sciences solutions segment in 2020, reflecting strong labware demand. Although growth normalized post-pandemic due to prior procurement of lab supplies, research expansion continues to support steady market progress.

Market Trends

Growing Focus on Biodegradable Labware

Environmental concerns surrounding single-use plastic labware are driving demand for biodegradable and reusable petri dishes. Research institutes and sustainability initiatives are encouraging green laboratory practices.

For example, in November 2022, Green Labs Austria, Merck KGaA, and the University of Vienna organized a workshop on sustainable lab solutions. Such initiatives are expected to promote eco-friendly product innovations and shape future market trends.

Market Drivers

Increasing R&D Activities in Healthcare

Rising global cases of infectious and chronic diseases are increasing pharmaceutical R&D investments. This directly drives demand for cell culture dishes and related consumables.

• Corning Incorporated invested USD 0.9 billion in R&D in 2022.
• Avantor Inc. generated USD 2,898.4 million revenue in 2022 from proprietary materials and consumables, reflecting 13.7% growth.
• GSK plc spent USD 6,533.3 million on R&D in 2022, marking a 9.3% increase year-over-year.

Growing collaborations between pharmaceutical companies, CROs, and CMOs are further accelerating research activities and product adoption.

Market Restraints

Rising Adoption of Alternatives

The increasing use of multiwell plates and PCR plates poses a challenge to traditional petri dish adoption. Multiwell plates offer high-throughput capabilities and convenience, making them attractive for advanced research applications.

For example, Thermo Fisher's 96-well microplates are priced around USD 9-10, while Merck's equivalent products cost USD 4-5, offering cost-efficient alternatives. Additionally, growing adoption of reusable labware to reduce plastic waste may limit demand growth.

Segmentation Analysis

By Product Type

The market is segmented into plastic and glass petri dishes.

• The plastic segment dominated with a 55.93% share in 2026, owing to affordability, durability, and chemical inertness.
• Plastic dishes are cost-effective; for instance, a Gosselin polystyrene petri dish costs around USD 412.15, while a PYREX glass dish costs approximately USD 733.0.
• The glass segment is expected to grow steadily due to reusability and resistance to repeated autoclaving, making it ideal for hospitals and research laboratories.

By End-User

The market is segmented into hospital & clinical laboratories, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others.

• The pharmaceutical & biotechnology companies segment dominated with 56.98% share in 2026, driven by rising drug development activities.
• The academic & research institutes segment is projected to grow considerably. According to CEIC data (2022), the U.S. has approximately 1.7 million researchers, supporting labware demand.

Regional Insights

North America

North America led the market with a valuation of USD 172.6 million in 2025. Growth is supported by expanding R&D facilities and pharmaceutical investments. For instance, in March 2023, Thermo Fisher opened a cell therapy facility in California to accelerate therapy development.

Asia Pacific

Asia Pacific is expected to grow at a considerable CAGR due to expanding biopharma manufacturing and distribution centers. In July 2023, Avantor expanded its Singapore hub to strengthen innovation and biopharma systems.

Europe

Europe holds a significant share, supported by personalized therapy initiatives and sustainable lab practices. Companies like SARSTEDT AG launched innovative cell culture plates in 2022 to enhance research efficiency.

Latin America & Middle East & Africa

These regions are expected to grow steadily due to increasing pharmaceutical collaborations and healthcare infrastructure development, such as Merck's vaccine facility support initiative in Nigeria.

Competitive Landscape

The market is fragmented, with leading players focusing on innovation, facility expansion, and partnerships. Key companies include:

• Corning Incorporated
• Thermo Fisher Scientific Inc.
• Merck KGaA
• SARSTEDT AG & Co. KG
• Greiner AG
• Avantor, Inc.
• Sumitomo Bakelite Co., Ltd.

Recent collaborations, product launches, and sustainability initiatives are strengthening competitive positioning.

Conclusion

The global petri dishes market is poised for steady growth, rising from USD 429.5 million in 2025 to USD 646.1 million by 2034, at a CAGR of 4.70%. Growth is primarily driven by expanding pharmaceutical R&D activities, increasing chronic disease prevalence, and advancements in cell culture research. While alternative labware products and sustainability concerns pose challenges, continuous innovation and rising global research investments will sustain market expansion through 2034.

Segmentation By Product Type

• Glass
• Plastic

By End-user

• Hospital & Clinical Laboratories
• Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

By Region

• North America (By Product Type, End-user, and Country)
  • U.S.
  • Canada
• Europe (By Product Type, End-user, and Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Rest of Europe
• Asia Pacific (By Product Type, End-user, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Rest of the World (By Product Type and End-user)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. R&D Expenditure, by Key Players, 2026
• 4.2. Qualitative Analysis on Ongoing Clinical Trials, 2026
• 4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• 4.4. Impact of COVID-19 on the Market

5. Global Petri Dishes Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Glass
  • 5.1.2. Plastic
• 5.2. Market Analysis, Insights and Forecast - By End User
  • 5.2.1. Hospital Labs & Clinical Labs
  • 5.2.2. Diagnostic Centers
  • 5.2.3. Pharmaceutical & Biotechnology Companies
  • 5.2.4. Academic & Research Institutes
  • 5.2.5. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Rest of the World

6. North America Petri Dishes Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Glass
  • 6.1.2. Plastic
• 6.2. Market Analysis, Insights and Forecast - By End User
  • 6.2.1. Hospital Labs & Clinical Labs
  • 6.2.2. Diagnostic Centers
  • 6.2.3. Pharmaceutical & Biotechnology Companies
  • 6.2.4. Academic & Research Institutes
  • 6.2.5. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Petri Dishes Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Glass
  • 7.1.2. Plastic
• 7.2. Market Analysis, Insights and Forecast - By End User
  • 7.2.1. Hospital Labs & Clinical Labs
  • 7.2.2. Diagnostic Centers
  • 7.2.3. Pharmaceutical & Biotechnology Companies
  • 7.2.4. Academic & Research Institutes
  • 7.2.5. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Italy
  • 7.3.5. Rest of Europe

8. Asia Pacific Petri Dishes Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Glass
  • 8.1.2. Plastic
• 8.2. Market Analysis, Insights and Forecast - By End User
  • 8.2.1. Hospital Labs & Clinical Labs
  • 8.2.2. Diagnostic Centers
  • 8.2.3. Pharmaceutical & Biotechnology Companies
  • 8.2.4. Academic & Research Institutes
  • 8.2.5. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.3.1. Japan
  • 8.3.2. China
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Rest of Asia Pacific

9. Rest of the World Petri Dishes Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Glass
  • 9.1.2. Plastic
• 9.2. Market Analysis, Insights and Forecast - By End User
  • 9.2.1. Hospital Labs & Clinical Labs
  • 9.2.2. Diagnostic Centers
  • 9.2.3. Pharmaceutical & Biotechnology Companies
  • 9.2.4. Academic & Research Institutes
  • 9.2.5. Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2026)
• 10.2. Company Profiles
  • 10.2.1. Corning Incorporated
    • 10.2.1.1. Overview
    • 10.2.1.2. Product
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. financials (Based on Availability)
  • 10.2.2. Thermo Fisher Scientific Inc.
    • 10.2.2.1. Overview
    • 10.2.2.2. Product
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. financials (Based on Availability)
  • 10.2.3. SARSTEDT AG & Co. KG
    • 10.2.3.1. Overview
    • 10.2.3.2. Product
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. financials (Based on Availability)
  • 10.2.4. Greiner AG
    • 10.2.4.1. Overview
    • 10.2.4.2. Product
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. financials (Based on Availability)
  • 10.2.5. Sumitomo Bakelite Co., Ltd.
    • 10.2.5.1. Overview
    • 10.2.5.2. Product
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. financials (Based on Availability)
  • 10.2.6. TPP Techno Plastic Products AG
    • 10.2.6.1. Overview
    • 10.2.6.2. Product
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. financials (Based on Availability)
  • 10.2.7. Avantor, Inc.
    • 10.2.7.1. Overview
    • 10.2.7.2. Product
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. financials (Based on Availability)
  • 10.2.8. Crystalgen, Inc.
    • 10.2.8.1. Overview
    • 10.2.8.2. Product
    • 10.2.8.3. SWOT Analysis
    • 10.2.8.4. Recent Developments
    • 10.2.8.5. Strategies
    • 10.2.8.6. financials (Based on Availability)
  • 10.2.9. Wuxi NEST Biotechnology Co., Ltd.
    • 10.2.9.1. Overview
    • 10.2.9.2. Product
    • 10.2.9.3. SWOT Analysis
    • 10.2.9.4. Recent Developments
    • 10.2.9.5. Strategies
    • 10.2.9.6. financials (Based on Availability)
  • 10.2.10. CELLTREAT Scientific Products
    • 10.2.10.1. Overview
    • 10.2.10.2. Product
    • 10.2.10.3. SWOT Analysis
    • 10.2.10.4. Recent Developments
    • 10.2.10.5. Strategies
    • 10.2.10.6. financials (Based on Availability)
  • 10.2.11. Phoenix Biomedical Products
    • 10.2.11.1. Overview
    • 10.2.11.2. Product
    • 10.2.11.3. SWOT Analysis
    • 10.2.11.4. Recent Developments
    • 10.2.11.5. Strategies
    • 10.2.11.6. financials (Based on Availability)
  • 10.2.12. Merck KGaA
    • 10.2.12.1. Overview
    • 10.2.12.2. Product
    • 10.2.12.3. SWOT Analysis
    • 10.2.12.4. Recent Developments
    • 10.2.12.5. Strategies
    • 10.2.12.6. financials (Based on Availability)
  • 10.2.13. Zhejiang Aicor Medical Technology Co.
    • 10.2.13.1. Overview
    • 10.2.13.2. Product
    • 10.2.13.3. SWOT Analysis
    • 10.2.13.4. Recent Developments
    • 10.2.13.5. Strategies
    • 10.2.13.6. financials (Based on Availability)
  • 10.2.14. MULTIGATE
    • 10.2.14.1. Overview
    • 10.2.14.2. Product
    • 10.2.14.3. SWOT Analysis
    • 10.2.14.4. Recent Developments
    • 10.2.14.5. Strategies
    • 10.2.14.6. financials (Based on Availability)